Pharmaceutical patent issues : interpreting GATT : hearings before the Committee on the Judiciary, United States Senate, One Hundred Fourth Congress, second session on examining the interrelationship between the intellectual property provisions of the GATT treaty implementing law and food and drug law and its impact on the creation of new breakthrough drugs and production of lower generic copies and S. 1277, a bill to provide equitable relief for the generic drug industry, and for other purposes, February 27, and March 5, 1996

CiNii Available at 1 libraries

Bibliographic Information

Title: "Pharmaceutical patent issues : interpreting GATT : hearings before the Committee on the Judiciary, United States Senate, One Hundred Fourth Congress, second session on examining the interrelationship between the intellectual property provisions of the GATT treaty implementing law and food and drug law and its impact on the creation of new breakthrough drugs and production of lower generic copies and S. 1277, a bill to provide equitable relief for the generic drug industry, and for other purposes, February 27, and March 5, 1996"

Publisher

Publication Year

Originally published: Washington : U.S. Government Printing Office, 1997

"S. Hrg. 104-878"

"Serial no. J-104-65"

Details 詳細情報について

Export